Status:
COMPLETED
Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?
Lead Sponsor:
Robert Krause, MD
Conditions:
Pulmonary Candidiasis
Invasive Candidiasis
Eligibility:
All Genders
18+ years
Brief Summary
In critically ill patients Candida spp. are frequently isolated from respiratory tract secretions such as endotracheal aspirates and bronchoalveolar lavages (BAL) and are most often considered as colo...
Detailed Description
In critically ill patients Candida spp. are frequently isolated from respiratory tract secretions such as endotracheal aspirates and bronchoalveolar lavages (BAL) and are most often considered as colo...
Eligibility Criteria
Inclusion
- depending on study group; i.e. no pathology of the lungs in group 1, and 4; underlying disease of the lungs in group 2 (i.e. sarcoidosis etc), infiltration of the lungs in group 3,4,5
Exclusion
- depending on study group: i.e. HIV, recent antifungal therapy, age below 18
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00786903
Start Date
November 1 2008
End Date
April 1 2015
Last Update
April 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, 8043